Medicare prescription drug price controls (S. 3)

Senate Roll Call No. 132
110th Congress, 1st Session

Rejected: 55-42 (see complete tally)

NRLC opposed this bill (S.3), sponsored by Sen. Max Baucus (D-Mt.), because it would create the conditions for effectively preventing older people from being allowed to spend their own money, if they choose, to save their own lives through access to unrationed prescription drugs under Medicare.  Under the guise of allowing “government negotiation” the bill would authorize the imposition of price controls that would limit access to and discourage the development of innovative life-saving medicines.  On the vote shown here, 55 senators voted in favor of a "cloture motion" to advance the bill.  This was five votes short of the 60 votes necessary to "invoke cloture" and overcome a “filibuster” led by Senator Charles Grassley (R-Iowa), so the bill did not advance.  A vote against cloture reflected the NRLC position.  [Majority Leader Harry Reid (D-Nv.) supported the bill, but was recorded among the 42 senators opposed to the cloture motion, because this allowed him to preserve the right to move to "reconsider" the vote at a later date if he so chooses.)  Roll call no. 132, April 18, 2007.  [To read NRLC's letter of April 17, 2007, to senators in opposition to S. 3, and for further information on the danger of drug rationing in Medicare, click here.]

Vote Map: Senate Roll Call No. 132
Votes For : 55
Votes Against : 42
Not Voting : 3

powered by CQ Roll Call ©2019